<2>Long term use of proton pump inhibitors and risk of stomach cancer: population based case-control study in five Nordic countries
<3>Corrected Study Details
The abstract of a recent paper by Onyinyechi Duru and colleagues, published in the BMJ on 21 January 2026, has been corrected to reflect the accurate end date of the study. The original report stated that the study concluded in 2000, but this has been updated to reflect the correct end date of 2020.
<3>Importance of Accurate Study Details
The accurate reporting of study details is crucial for the integrity and reliability of scientific research. In this case, the correction of the study end date is essential for understanding the context and implications of the study’s findings. The correction also highlights the importance of verifying information through multiple sources to ensure accuracy.
<3>Background and Rationale
Proton pump inhibitors (PPIs) are commonly used medications to treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. However, long-term use of PPIs has been linked to an increased risk of stomach cancer. The study in question aimed to investigate the association between long-term PPI use and the risk of